Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pragmatic randomized trial of therapeutic strategies for SSRI-resistant major depressive disorder
2007-002130-11Phase 4Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of venlafaxine, nortriptyline, fluoxetine, sertraline, paroxetine and 3 more in major depressive disorder (MDD) (5 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoints: Remission of depressive symptoms and Hamilton Depression Rating Scale 17-item score. Started Jan 2008; status: active.
02
Drugs
venlafaxinenortriptylinefluoxetinesertralineparoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-002130-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002130-11.